IL6 and myeloid sarcoma: Therefore, in this study, we prospectively evaluated the expression of KFLC biomarkers and CSF concentration of IL-1β, sIL-2R (CD25), IL-6, and IL-10, and we correlated each biomarker measurement with diagnosis in patients referred to our MS center for suspected MS.